Journal for ImmunoTherapy of Cancer

Titel Veröffentlichungsdatum Sprache Zitate
LAG-3: from molecular functions to clinical applications2020/09/01English235
Targeting the indoleamine 2,3-dioxygenase pathway in cancer2015/12/01English230
Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial2018/01/19English228
Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma2015/04/21English228
Collagen density regulates the activity of tumor-infiltrating T cells2019/03/12English220
Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity2020/11/01English219
Tim-3 finds its place in the cancer immunotherapy landscape2020/06/01English215
Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade2018/06/04English210
Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study2019/05/22English208
Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth2019/11/27English206
A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors2018/11/23English206
Tumor mutational burden quantification from targeted gene panels: major advancements and challenges2019/07/15English200
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations2018/12/01English198
Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer2017/03/21English194
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience2019/01/06English191
PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma2019/11/29English187
Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer2020/02/01English186
Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature2019/04/16English184
Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma2018/01/22English180
Exploring the emerging role of the microbiome in cancer immunotherapy2019/04/17English178
Oncolytic virus immunotherapy: future prospects for oncology2018/12/01English177
Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1+ regulatory B cell expansion2018/12/01English177
Clinical landscape of oncolytic virus research in 20202020/10/01English176
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics2019/01/09English173
Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study2015/06/16English172
Evaluation of dosing strategy for pembrolizumab for oncology indications2017/05/16English172
A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines2017/05/16English171
B cell regulation of the anti-tumor response and role in carcinogenesis2016/07/19English170
CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma2019/11/14English170
Resident memory T cells, critical components in tumor immunology2018/09/04English169